Spectroscopic Approaches to Tracking Metal-based Drugs in Cells and Tissue

Anna K Renfrew1

  • 1School of Chemistry, The University of Sydney 2006 Sydney NSW, Australia;,

Chimia
|March 30, 2017
PubMed

Insights

Novel metal-based drugs require advanced imaging techniques. This review explores synchrotron X-ray fluorescence, mass spectrometry, and fluorescence microscopy for mapping these compounds in cells, focusing on ruthenium drugs.

Area of Science:

  • Medicinal Chemistry
  • Biophysical Chemistry
  • Cellular Imaging

Background:

  • Development of metal-based drugs as alternatives to platinum(II) chemotherapeutics.
  • Need for advanced imaging techniques to understand novel drug behavior in cells and tissues.
  • Challenges in mapping metal ions and complexes within cellular environments.

Purpose of the Study:

  • To review and compare three key imaging modalities for metal-based drugs.
  • To highlight the advantages and limitations of each technique.
  • To emphasize their application in visualizing ruthenium-based drugs.

Main Methods:

  • Discussion of synchrotron radiation-induced X-ray fluorescence (SRIXF).
  • Analysis of mass spectrometry (MS) techniques.
  • Evaluation of fluorescence microscopy (FM) methods.

Main Results:

  • SRIXF offers high sensitivity for elemental mapping.
  • MS provides molecular and isotopic information.
  • FM allows for real-time visualization of drug localization.
  • Each method has unique strengths and weaknesses for imaging metal complexes.

Conclusions:

  • Effective imaging of metal-based drugs is crucial for therapeutic development.
  • Choosing the appropriate imaging technique depends on the specific research question.
  • Further development of imaging strategies is needed for ruthenium-based drug research.